MONMOUTH JUNCTION, N.J. , April 5, 2022 /PRNewswire/ — CytoSorbents Corporation (NASDAQ: CTSO), a leader in the treatment of life-threatening conditions in the intensive care unit and cardiac surgery using blood purification, announces the appointment of Ms. Jiny Kim, MBA to CytoSorbents’ Board of Directors as a new independent director, effective immediately, for a term expiring at […]
Other News
Respira Therapeutics Announces First Patient Dosed in Phase 2b VIPAH-PRN 2b Trial of RT234 in Patients with Pulmonary Arterial Hypertension (PAH)
First clinical trial to evaluate the safety & efficacy of RT234 on exercise parameters assessed by Cardiopulmonary Exercise Testing (CPET) PALO ALTO, Calif., April 5, 2022 /PRNewswire/ — Respira Therapeutics, Inc. a clinical-stage company developing inhaled therapeutics for cardiopulmonary diseases that improve patient outcomes through enhanced drug targeting to the small airways of […]
Humacyte Expands Leadership Team with Appointment of Shamik Parikh, M.D., as Chief Medical Officer
–Seasoned physician, scientist and life science executive brings expertise in clinical research and development across product life cycle– –Key appointment as Humacyte advances HAV through multiple late-stage clinical trials in initial vascular applications– DURHAM, N.C., April 05, 2022 (GLOBE NEWSWIRE) — Humacyte, Inc. (Nasdaq: HUMA), a clinical-stage biotechnology platform company […]
Claritas Announces Approval from Australian Ethics Committee to Begin Phase 1 Trial of R-107
SAN FRANCISCO, CA and TORONTO, ON, April 05, 2022 (GLOBE NEWSWIRE) — Claritas Pharmaceuticals, Inc. (TSX VENTURE EXCHANGE: CLAS and OTC: CLAZF) (the “Company” or “Claritas“) today announced that the Australian Human Research Ethics Committee has approved the Company’s submission for the Phase 1 clinical study of R-107 to be conducted […]
Multi-center Clinical Study Data on Anaconda Biomed’s Mechanical Thrombectomy System Published in Stroke
ANA System Shown to Achieve High Rate of Complete Recanalization, Favorable 90 Day Outcomes BARCELONA, Spain–(BUSINESS WIRE)–Multi-center clinical study data supporting Anaconda Biomed’s ANA Advanced Neurovascular Access™ (ANA) Catheter System for treating ischemic stroke has been published in the journal Stroke. The SOLONDA (“SOL”itaire in combination with the ANA Catheter system manufactured […]
Ra Medical Systems Granted U.S. Patent for Laser Ablation Catheters with Expanded Ablation Area
CARLSBAD, Calif.–(BUSINESS WIRE)–Ra Medical Systems, Inc. (NYSE American: RMED), a medical device company focusing on developing its excimer laser system to treat vascular diseases, announces the United States Patent and Trademark Office has granted the company a patent for liquid-filled laser ablation catheters with expanded distal optical windows. U.S. patent […]
LimFlow Raises $40 Million (€36 Million) in Series D Financing
Funds to Support Completion of Clinical Program Through Commercialization of Novel Device Designed to Prevent Amputations in Patients with Chronic Limb-Threatening Ischemia PARIS–(BUSINESS WIRE)–LimFlow SA, a pioneer in the development of minimally-invasive technology for the treatment of chronic limb-threatening ischemia (CLTI), a severe form of peripheral artery disease (PAD), today announced […]
Study Demonstrates that Cardiologs’ AI Dramatically Reduces Inconclusive Apple Watch ECGs
Data being presented at the EHRA 2022 shows Cardiologs’ deep neural network model is better than Apple Watch ECG 2.0 algorithm at detecting & classifying irregular heart rhythms Paris and Boston, Mass. –April 5, 2022 – Cardiologs, a global leader in artificial intelligence (AI) cardiology diagnostics, today announced the results […]
Zio® by iRhythm Shown to Prevent Hospital Admissions, Aid in Early Detection of AF
New clinical research presented at ACC.22 shows that the Zio service is a viable solution for the early detection of silent atrial fibrillation Additional data shows that Zio AT can positively impact hospital resources – saving one healthcare system 136 inpatient hospitalization days SAN FRANCISCO, April 03, 2022 (GLOBE NEWSWIRE) — iRhythm […]
ABBOTT RECEIVES FDA APPROVAL FOR AVEIR™ VR LEADLESS PACEMAKER SYSTEM TO TREAT PATIENTS WITH SLOW HEART RHYTHMS
Abbott’s Aveir single chamber (VR) pacing system is the world’s only leadless pacemaker with a unique mapping capability to assess correct positioning prior to placement Aveir VR has an increased projected battery life that can be up to two times longer than other commercially available leadless pacemakers when using the […]



